# Large Investors Accelerate Medical Device Recalls Institutional ownership leads to faster removal of risky products from the market. - **Source:** [Journal of Operations Management](https://onlinelibrary.wiley.com/journal/18731317) - **Published:** 2026-07-02 - **Topic:** [Business](https://brifing.si/c/business) - **Original article:** - **On Brifing:** https://brifing.si/s/0f21e35a-dd86-4fcb-b9bb-28f9950da113 ## Risks of Recall Delays Late detection of critical defects in medical devices prolongs patient risk and damages company reputations. Analysis of 2,932 recalls across 69 firms (2002-2020) reveals delays as a persistent issue in the healthcare sector. ## Institutional Investors' Oversight A 1% increase in large institutional ownership correlates with 24 fewer days to recall. Investors actively monitor management, prompting quicker corrective actions for defective products. ## R&D Intensity as Moderator The positive effect weakens in firms with high R&D expenditures. Complex product portfolios complicate oversight mechanisms and slow decision-making processes. ## High-Risk Devices Show Different Patterns For life-critical devices like pacemakers, investor influence is less pronounced. Strict regulations and legal risks already compel all stakeholders to act swiftly. ## Policy Implications Regulators should consider this beneficial investor role in operational decisions. Transparency-enhancing policies could strengthen monitoring and improve patient safety outcomes. ## Shifting Industry Paradigms Findings reveal institutional investors shape not just financials but operational choices. An 'active investor' model in healthcare may balance patient and shareholder interests effectively. ## Sources covering this story - https://onlinelibrary.wiley.com/doi/10.1002/joom.70047?af=R — --- _Summary written by Brifing from the original reporting. Copyright in the original article belongs to its publisher; read the full piece at the link above._